News

Archive: August, 2022

DoD Awards Synthetic Human Antibody Prototype Agreement to Treat High-Priority Toxins and Pathogens
August 24, 2022 — JPM CBRN Medical awarded a prototype agreement through Army Contracting Command with GigaGen, Inc., a subsidiary of Grifols. This agreement will evaluate if GigaGen’s novel platform capabilities can rapidly create a fully-synthetic human antibody product to protect against botulinum neurotoxins (BoNT) A and B. The prototype agreement can support follow-on testing against other DoD-priority toxins and pathogens, as well as advanced development activities including manufacturing and clinical testing to demonstrate improved potency and military utility. ... MORE

FDA Approves New Drug Application for the DoD’s Advanced Anticonvulsant System Program
August 24, 2022 — JPM CBRN Medical received notice of U.S. Food and Drug Administration (FDA) approval of Rafa's midazolam injection autoinjector New Drug Application. The Defense Department (DoD) developed the product with Rafa, via JPM CBRN Medical’s Advanced Anticonvulsant System (AAS) program team. The DoD’s Chemical and Biological Defense Program supported this effort... MORE

Senior U.S. Army civilian retires from Department of Defense's premier all hazards command
August 19, 2022 — The senior Army civilian at the Department of Defense’s premier multifunctional all hazards command completed more than 43 years of uniformed and civilian service, Aug. 18. Dr. Mark W. Fishback retired from the 20th Chemical, Biological, Radiological, Nuclear, Explosives (CBRNE) Command during a widely attended ceremony on Aberdeen Proving Ground, Maryland... MORE

Dr. Mark W. Fishback retired from the 20th Chemical, Biological, Radiological, Nuclear, Explosives (CBRNE) Command as the deputy to the commanding general and senior U.S. Army civilian

News Search

News Archive - Search by Year and Month

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.